Turmeric Anti-Inflammatory and Cell-Damage Trial
NCT02815475 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2016-09-09
Summary
This trial will be conducted for the BBC. The aim of the project is to assess if consuming the spice turmeric every other day, in the amount consumed in a curry, can reduce cell damage and inflammation. The results of the project will be used to inform the TV program Trust Me I'm a Doctor.
Conditions
- Healthy Adults
Interventions
- DIETARY_SUPPLEMENT
-
Placebo comparator
- DIETARY_SUPPLEMENT
-
Curcumin
- DIETARY_SUPPLEMENT
-
Turmeric powder
Sponsors & Collaborators
-
British Broadcasting Corporation
collaborator INDUSTRY -
University College, London
collaborator OTHER -
University of Leeds
collaborator OTHER -
PB Biosystems Ltd
collaborator UNKNOWN -
Newcastle University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-03-31
- Primary Completion
- 2016-08-31
- Completion
- 2016-08-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Curcumin and Cholecalciferol in Treating Patients With Previously Untreated Stage 0-II Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
NCT02100423 ·Status: COMPLETED ·Phase: PHASE2
-
Curcumin for the Chemoprevention of Colorectal Cancer
NCT00118989 ·Status: TERMINATED ·Phase: NA
-
Bio-availability of a New Liquid Tumeric Extract
NCT00542711 ·Status: WITHDRAWN ·Phase: PHASE1
-
Study Investigating the Ability of Plant Exosomes to Deliver Curcumin to Normal and Colon Cancer Tissue
NCT01294072 ·Status: RECRUITING ·Phase: NA
-
Curcumin (Diferuloylmethane Derivative) With or Without Bioperine in Patients With Multiple Myeloma
NCT00113841 ·Status: COMPLETED ·Phase: NA
-
Effect of Curcumin Addition to Standard Treatment on Tumour-induced Inflammation in Endometrial Carcinoma
NCT02017353 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I Study of Surface-Controlled Water Soluble Curcumin (THERACURMIN CR-011L)
NCT01201694 ·Status: COMPLETED ·Phase: PHASE1
-
Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer
NCT04731844 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Curcuminoids on Aberrant Crypt Foci in the Human Colon
NCT00176618 ·Status: TERMINATED ·Phase: NA
-
Efficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma Patients
NCT01269203 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)
NCT06097663 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of a Prebiotic Food-enriched Diet (PreFED) in Combination With Ipilimumab/Nivolumab Combination Immune Checkpoint Blockade (ICB) in ICB-refractory Melanoma Patients
NCT06250335 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women
NCT00088972 ·Status: TERMINATED ·Phase: PHASE2
-
Celecoxib as a Chemopreventive Agent in Current and Former Smokers
NCT00981201 ·Status: COMPLETED ·Phase: PHASE3
-
Bromelain, Comosain as a New Drug for Treating and Preventing Various Types of Cancer in the Humans
NCT02340845 ·Status: UNKNOWN ·Phase: PHASE2
-
Autoimmunity After Checkpoint Blockade
NCT04119713 ·Status: RECRUITING
-
The Efficacy of Coenzyme Q10 And Curcumin in Patients With Myelodysplastic Syndromes
NCT00247026 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Research for Pathophysiology of Cancer Related Fatigue (CRF) and Chronic Fatigue (CFS/ME)
NCT03773003 ·Status: RECRUITING ·Phase: NA
-
Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses
NCT03185871 ·Status: WITHDRAWN ·Phase: PHASE2
-
Celecoxib in Treating Patients With Precancerous Lesions of the Mouth
NCT00014404 ·Status: COMPLETED ·Phase: PHASE2
-
Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
NCT00101335 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial on Ganoderma Spore Lipids Combined With Chemo in Patients With G.I. Cancers
NCT02785523 ·Status: UNKNOWN ·Phase: PHASE3
-
Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease
NCT00541164 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses
NCT00027976 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Effect of Celecoxib on Perioperative Inflammatory Response in Colon Cancer
NCT01284504 ·Status: TERMINATED ·Phase: NA